Search results
Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disease in which tense subepithelial blisters appear at sites of trauma. Unlike EB, EBA is not inherited and usually presents in adult life.
29 paź 2023 · Epidermolysis bullosa acquisita (EBA) is a rare, chronic autoimmune blistering disease that affects both the skin and mucous membranes. This condition arises due to autoantibodies targeting type VII collagen—a crucial component of anchoring fibrils within the dermal-epidermal junction.
1 lut 2023 · Epidermolysis bullosa acquisita (EBA) is a rare chronic autoimmune subepidermal blistering disease of the skin and mucous membranes, usually beginning in adulthood. EBA is induced by autoantibodies to type VII collagen, a major component of anchoring fibrils in the dermal–epidermal junction (DEJ).
8 sie 2021 · Epidermolysis bullosa acquisita (EBA) is a rare immunobullous condition in which patients may have chronic acquired, trauma-induced, subepidermal blistering, or a clinical picture similar to bullous pemphigoid. EBA has a distinctive immunopathology.
29 kwi 2024 · Epidermolysis bullosa acquisita (EBA) is a rare, sporadic, subepithelial, mucocutaneous blistering disease that usually develops in adulthood. EBA is classically described as a mechanobullous disorder characterized by skin fragility, noninflammatory tense bullae, milia, and scarring.
12 cze 2024 · Researchers are studying better ways to treat and relieve the symptoms of epidermolysis bullosa, including: Gene therapy, including a gel applied to wounds of people with dystrophic epidermolysis bullosa; Bone marrow (stem cell) transplantation; Protein replacement therapies; Other cell-based therapies
11 cze 2022 · In the inflammatory form of epidermolysis bullosa acquisita, urticarial inflammatory plaques with tense bullae, similar to bullous pemphigoid, or mucosal lesions can determine permanent scars and loss of functionality in the ocular, oral, esophageal, and urogenital regions.
